CaliPharms Total Revenue

CaliPharms (KGET) currently reports a total revenue of $110K as of September 2014. In the prior-year period, the figure was $0. That is below the Industrials sector average of $380B. Use the charts on this page to explore CaliPharms's total revenue history and peer comparisons.

CaliPharms's total revenue changed from $0 to $110K (period ending September 2014). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CaliPharms's total revenue of $110K is lower than the Industrials sector average of $380B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

CaliPharms reported $110K in total revenue as of September 2014. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $110K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is $380B. From there, open related valuation or income-statement pages for CaliPharms, and consider following KGET for alerts when major investors trade the stock.